REGENXBIO Inc. Restructuring Reserve, Period Increase (Decrease)
REGENXBIO Inc. (RGNX) reported Restructuring Reserve, Period Increase (Decrease) of -$400.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodIncreaseDecrease · last filed 2026-03-05
- REGENXBIO Inc. restructuring reserve, period increase (decrease) for the quarter ending 2024-12-31 was $0.00.
- REGENXBIO Inc. restructuring reserve, period increase (decrease) for the quarter ending 2024-09-30 was $0.00.
- REGENXBIO Inc. restructuring reserve, period increase (decrease) for the quarter ending 2024-06-30 was -$100.00K.
- REGENXBIO Inc. restructuring reserve, period increase (decrease) for the quarter ending 2024-03-31 was -$300.00K.
- REGENXBIO Inc. restructuring reserve, period increase (decrease) for fiscal 2024 was -$400.00K.
| Period end | Restructuring Reserve, Period Increase (Decrease) 3 month | Restructuring Reserve, Period Increase (Decrease) 6 month | Restructuring Reserve, Period Increase (Decrease) 9 month | Restructuring Reserve, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | -$100.00K derived: sum of 3 quarters · filed 2026-03-05 | -$400.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$100.00K derived: sum of 2 quarters · filed 2024-11-06 | -$400.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$400.00K 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | -$300.00K 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |